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Abstract
Pancreatic necrosis is a highly morbid condition. It is most commonly associated 
with severe, acute pancreatitis, but can also be caused by trauma or chronic pancre-
atitis. Once diagnosed, management of pancreatic necrosis begins with supportive 
care, with an emphasis on early, and preferably, enteral nutrition. Intervention 
for necrosis, sterile or infected, is dictated by patient symptoms and response to 
conservative management. When possible, intervention should be delayed to allow 
the necrotic collection to form a capsule. First-line treatment for necrosis is with 
percutaneous drainage or endoscopic, transmural drainage. These strategies can be 
effective as monotherapy, but the need for repeated interventions, or for progres-
sion to more invasive interventions, is not uncommon. Necrosectomy may be per-
formed using a previously established drainage tract, as in percutaneous endoscopic 
necrosectomy (PEN), video-assisted retroperitoneal debridement (VARD), and 
direct endoscopic necrosectomy (DEN). Although outcomes for these minimally-
invasive techniques are better than for traditional necrosectomy, both laparoscopic 
and open techniques remain important for patients with extensive disease that 
cannot otherwise be adequately treated. This is especially true when pancreatic 
necrosis is complicated by disconnected pancreatic duct syndrome (DPDS), where 
necrosectomy remains standard of care.
Keywords: necrotizing pancreatitis, pancreatic necrosis, percutaneous, endoscopic, 
pancreatectomy, necrosectomy
1. Introduction
Pancreatic necrosis is the presence of nonviable pancreatic parenchyma or 
peripancreatic fat which may be localized or diffuse. It is classified radiologically 
according to the Atlanta Criteria as an acute necrotic collection (ANC), which is 
defined as a non-encapsulated area of necrosis, or as walled-off necrosis (WON), 
which is encapsulated. [1] Although pancreatic necrosis may result from trauma, 
malignancy, or chronic pancreatitis, the most common cause is acute pancreatitis; 
20% of patients with acute pancreatitis develop necrosis. For patients who develop 
necrosis, the mortality rate is 15–30%. [2] Surgery has historically been the primary 
treatment for pancreatic necrosis. However, the superior outcomes associated with 
new, less invasive techniques have narrowed the scope for surgical intervention. 
Despite these shifts in practice, surgical care remains an important tool for the 
treatment of pancreatic necrosis.
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2. Diagnosis and conservative management
Although the diagnosis of pancreatitis is generally clinical, the primary diag-
nostic tool for pancreatic necrosis is the computed tomography (CT) scan. With 
this modality, normal pancreatic parenchyma is low attenuation, 40–50 Hounsfield 
units (HU), but increases with contrast to 100–150 HU. In comparison, areas of 
necrosis remain hypoattenuating, <30 HU. [3] MRI and endoscopic ultrasound 
are also used, but CT scan is considered to be the gold standard for diagnosis and 
characterization. [4]
Regardless of the presence of necrosis, fluid resuscitation, and early nutritional 
support are paramount to the treatment of patients with acute pancreatitis. For 
patients who are able to tolerate enteral nutrition, there is a significant reduction in 
the rates of infected pancreatic necrosis, multiorgan failure, surgical intervention, 
and mortality when compared to patients who are given total parenteral nutrition 
(TPN). [5, 6] Thus, prior to initiation of TPN, patients should be evaluated for 
tolerance of oral, nasogastric, and nasojejunal feeding. Route notwithstanding, 
nutrition should be addressed in the first 24–48 hours of admission for acute 
pancreatitis. [7]
Sterile pancreatic necrosis does not have a specific clinical presentation, but 
is more common in patients with symptoms lasting more than 48 hours and with 
concomitant organ failure. [8] The morbidity and mortality associated with 
pancreatic necrosis is exacerbated by development of infection, which may result 
of seeding associated with bacteremia, colonic bacterial translocation, or direct 
contamination from a procedure (e.g. endoscopic retrograde cholangiopancrea-
tography (ERCP) or surgery). [9] The risk of infection correlates with the degree 
of necrosis. If more than 30% of the pancreatic parenchyma is necrotic, there is a 
22% risk of infection. If 30–50% is necrotic, the risk of infection is 37%. If necrosis 
exceeds 50%, the risk of infection is 46%. [10] The signs and symptoms of infected 
pancreatic necrosis are similar to those of other types of infection, including: fever, 
leukocytosis, and worsening condition with optimal supportive care. Once the 
necrosis becomes infected, the incidence of organ failure increases, along with the 
risk of mortality. [11]
Differentiating sterile from infected necrosis based on clinical presenta-
tion can be difficult. Patients with sterile necrosis can proceed to organ failure 
in similar fashion to patients with infected necrosis. Infection can be detected 
non-invasively on CT scan by looking for the presence of gas locules within the 
area of necrosis, suggesting microbial gas production. However, these findings 
are not always seen on CT, and fine-needle aspiration (FNA) may be necessary for 
definitive diagnosis. Multiple FNA aspirates may be required due to the 10% false 
negative rate of this test. [12]
However, proof of infection on radiology or by tissue culture is not necessary 
to initiate treatment. If infection is strongly suspected due to clinical course, 
antibiotics are indicated regardless of radiologic or tissue diagnosis. If no antibiotic 
sensitivities are available from culture results, broad-spectrum antibiotics should be 
started. Due to the ability to penetrate the necrotic tissue, carbapenems are consid-
ered first-line treatment. [13] Prophylactic use of antibiotics has not been shown to 
impact the rate of developing infected necrosis, systemic complications, mortality, 
or need for surgical intervention and is not recommended [14–16].
Prior to any invasive management, a patient should be treated with optimal 
supportive care. This includes fluid resuscitation, nutritional support, and antibiot-
ics, if infection is suspected. The need for invasive management of sterile pancreatic 
necrosis is rare, especially in acute phase. However intervention may be necessary 
during the late phase for protracted abdominal pain, obstruction, or, less often, for 
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failure of clinical improvement. Infected necrosis requires invasive intervention 
more often, both in order to gain source control and in order to resolve other non-
infectious symptoms. [17]
3. Percutaneous and endoscopic interventions
Although percutaneous and endoscopic interventions have historically been 
considered temporizing measures, not definitive management, many patients 
with pancreatic necrosis are successfully treated with these techniques, without 
need for more invasive therapy. Percutaneous drainage can successfully treat acute 
necrotizing pancreatitis in more than 50% of patients without need for surgical 
necrosectomy. The success rate with endoscopic therapy can reach 80% when used 
in conjunction with DEN. [18, 19] Thus, development of less invasive methods 
for addressing pancreatic necrosis led to a decrease in the indications for surgical 
intervention. The choice of intervention, percutaneous or endoscopic, is dependent 
on the situation, timing, and accessibility of the area of necrosis. (Figure 1).
Endoscopic management of pancreatic necrosis is performed transmurally, 
either across the duodenum, for pancreatic head necrosis, or the stomach, for neck 
or body necrosis. Although technically feasible earlier in the clinical course, endo-
scopic intervention should be delayed to 4 weeks after onset of symptoms in order 
for an appropriate capsule to form around the necrotic tissue. [20] In cases where 
intervention can be delayed until WON form, and the WON is accessible transmu-
rally, this is considered first-line intervention. [18]
With or without the aid of endoscopic ultrasound (EUS), a plastic or self-
expanding metal stent (SEMS) is placed from the lumen of the duodenum or 
stomach into the area of WON. In addition to allowing the WON to drain into the 
Figure 1. 
Flowchart for Management of Pancreatic Necrosis after Failure of conservative management. After failure 
of conservative management – Supportive care, antibiotics, and nutrition – The appropriate intervention 
depends on the nature of the necrosis. If it is associated with a disconnected duct, a separate pathway, which 
ends with distal pancreatectomy, internal drainage, or endoscopic translumenal stent placement, is indicated. 
If there is no disconnected duct, the correct pathway is dictated by the stage of necrosis, as a nonencapsulated 
acute necrotic collection or as walled off necrosis. Endoscopic and percutaneous strategies are preferred in each 
situation, and traditional, laparoscopic or open necrosectomy serves as the final option for patients that fail 
other management, or in hospitals without resources or staff to perform other procedures.
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lumen, these stents also allow access to the area for debridement, via irrigation 
or DEN. [21] (Figure 2) In DEN, an endoscope with one or two working ports is 
advanced through the previously placed, transluminal stent. Upon entering the 
WON, a number of tools, including forceps and snares are used to remove debris 
that would otherwise not be susceptible to removal with irrigation. [21] On average, 
3–6 endoscopic interventions are necessary prior to resolution of necrosis. [22]
DEN was first compared to surgical necrosectomy in the Pancreatitis, 
Endoscopic Transgastric vs. Primary Necrosectomy in Patients with Infected 
Necrosis (PENQUIN) Trial. In this trial, patients in the surgery group underwent 
a number of different operations, including 6 video-assisted retroperitoneal 
debridement (VARD) surgeries, 4 open necrosectomies, and 2 percutaneous 
drainage placements without need for more invasive therapy. The two patient 
who did not have a necrosectomy were excluded from final statistical analysis. 
All 10 patients in the endoscopic group had ultrasound guided stent placement, 
irrigation, and DEN. Following intervention, the rates of new-onset organ failure 
and pancreatic fistula were lower in the endoscopic group. The trial also com-
pared the groups with regard to a composite clinical outcome, which included 
major post-operative complications and mortality, and found a lower rate in the 
endoscopic group. [23, 24] These findings were later replicated in the Minimally-
invasive Surgery Versus Endoscopy Randomized (MISER) Trial. Additionally, 
MISER showed lower rates of pancreatic fistula formation and a higher quality of 
life at 3 months after surgery in the endoscopic group. [25] In the Transluminal 
Endoscopic Step-up Approach Versus Minimally-invasive Surgical Step-up 
Approach in Patients with Infected Necrotizing Pancreatitis (TENSION) Trial, a 
larger randomized trial, no difference in mortality was observed. However, the 
rates of pancreatic fistula and length of stay favored the endoscopic group. [26]
Percutaneous drainage is preferable in patients that are deemed too unstable 
to tolerate endoscopic drainage or if the area of necrosis extends into a dependent 
Figure 2. 
Surgical approaches to Necrosectomy. Access the lesser sac and retroperitoneum for the purposes of pancreatic 
necrosectomy can be achieve through a number of approaches. Direct endoscopic necrosectomy (DEN) is 
performed by accessing the stomach via the esophagus and then creating a posterior gastrotomy. The transgastric 
approach, performed laparoscopically or open, requires both an anterior and a posterior gastrotomy. The 
lesser sac can also be accessed by opening the gastrocolic ligament or transverse mesocolon, either by traversing a 
previously established, drainage tract or with a surgical approach.
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space, such as the paracolic gutters or pelvis. It is also an acceptable alternative when 
endoscopic drainage is unavailable or not technically feasible, specifically in the set-
ting of ANC, when there is no capsule that could support an endoscopic stent. [27]
Percutaneous drainage is usually CT-guided, although ultrasound-guided drain-
age can also be performed. These drains may be transperitoneal, with the external 
portion of the drain fixed in the anterior abdominal wall. These drains may also be 
placed through the flank, directly into the retroperitoneum, without traversing the 
peritoneum. In addition to draining ANC and WON, percutaneous drains can also 
be used for irrigation. [28]
Although percutaneous drainage is successful as monotherapy in some patients, 
patients with larger areas of necrosis, multifocal necrosis, incomplete liquefaction, 
and pre-procedural organ failure are less likely to be adequately treated. While some 
of these factors can be overcome with larger drainage catheters, for these reasons, 
percutaneous drainage remains a bridge to therapy, allowing patients to survive the 
acute period of disease, and undergo definitive management later, with improved 
outcomes. [26, 29, 30]
4. General considerations for surgical management
Surgical management may be minimally-invasive or open, but has the same 
two primary goals: obtaining source control by removing as much necrotic tissue 
as possible and providing access for irrigation and drainage. As a general principle, 
minimally-invasive approaches are preferred to open necrosectomy as first-line 
treatment. The improved outcomes of minimally-invasive technique lead to devel-
opment of the “step-up” approach to management, which begins with percutaneous 
or endoscopic intervention, followed by a progression to surgical intervention as 
indicated by unresolved disease. However, the final treatment decision is dictated 
by the patient, surgeon, and available resources. A second principle is that surgical 
intervention should be delayed as long as possible in order to improve outcomes. 
Operating during the early, acute phase of pancreatitis, especially in the presence of 
ANC, rather than WON, is associated with higher morbidity and mortality regard-
less of surgical approach. A third principle is that long-term nutritional access, 
through a gastrostomy or gastrojejunostomy tube, should be obtained prior to con-
cluding the procedure if no other method for enteral feeding has been established. 
Fourth, a cholecystectomy may also be performed if gallstones were implicated in 
the etiology of pancreatitis, provided the patient is adequately stable to undergo an 
additional procedure. (Figure 1).
5. Minimally-invasive Necrosectomy
VARD is a technique, used as the final phase of the step-up approach, where the 
retroperitoneum is accessed through a previously established, left flank, percutane-
ous drainage tract. (Figure 2) The tract is then serially dilated, in order to accom-
modate progressively larger drainage catheters. At the time of surgery, in order to 
facilitate introduction of laparoscopic instruments, a small, 4–6 centimeter incision 
is made where the tract exits the skin. After confirming entry into the WON with a 
probe, tissue and fluid are removed with suction. The laparoscope is then inserted, 
with or without CO2 insufflation, for continued debridement under direct visualiza-
tion, using blunt laparoscopic forceps. Following debridement, again under direct 
visualization, large drainage catheters or chest tubes, 28-French or greater, are placed. 
After surgery, these catheters are used for repeated lavage as well as for drainage. [31]
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The superiority of VARD, and the step-up approach, compared to surgery for 
the treatment of necrotizing pancreatitis was first published in the Minimally-
invasive Step-up Approach Versus Maximal Necrosectomy in Patients with Acute 
Necrotizing Pancreatitis (PANTER) Trial. In this study, 35% of the patients 
assigned to the step-up arm were successfully treated with percutaneous drainage 
alone. When comparing the step-up and surgical groups, the step-up group was less 
likely to have new-onset organ failure, less likely to develop an incisional hernia, 
and had an overall lower rate of endocrine insufficiency. However, the mortality 
rate was not significantly different, 19% in the step-up group versus 16% in surgery 
group. [31]
A similar procedure, percutaneous endoscopic necrosectomy (PEN), can be 
performed utilizing a previously established percutaneous drainage tract. Unlike 
VARD, PEN utilizes a flexible endoscope, as compared to a rigid laparoscope. 
Because the endoscope has working ports, in addition to irrigation and suction, an 
additional incision around the tract is not needed. Also unlike VARD, PEN can be 
performed at bedside, with conscious sedation. [32]
PEN was shown to be effective in a large, prospective study of 171 patients 
with infected pancreatic necrosis. The primary outcome investigated was con-
trol of sepsis and resolution of the infected collection. In this study, 18 of 26 
(69%) patients with infected ANC and 23 of 27 (85%) with infected WON who 
underwent PEN were successfully treated, while the remainder required surgical 
necrosectomy. Predictors of failure included >50% parenchymal necrosis and early 
organ failure. ANC was not predictive. The overall mortality rate for this study was 
38%. [32, 33] Although this technique has not been directly compared to surgery, 
VARD, or transmural endoscopy, this study demonstrated the safety and utility of 
PEN in patients with infected pancreatic necrosis.
Regardless of the type of minimally-invasive drainage, VARD or PEN, it 
has been shown that the “step-up approach,” beginning with drainage and 
progressing to debridement, is superior to upfront surgical approaches in terms 
of mortality, rates of pancreaticocutaneous fistula formation, and long-term 
morbidity. [25, 30, 34]
6. Transgastric necrosectomy
In addition to utilizing a percutaneous drainage tract for necrosectomy, access 
can also be gained through the stomach. By entering the abdomen and opening the 
anterior wall of the stomach and then opening the posterior aspect of the stomach, 
access to the lesser sac and underlying pancreas is achieved. (Figure 2) An aperture 
between the WON and posterior wall of the stomach is then created, either with 
sutures or by stapling, providing a definitive drainage tract. This tract is then used 
for necrosectomy following the same principles as DEN.
This approach is most well suited for WON limited to the lesser sac. When there 
is extensive necrosis extending to the retroperitoneum or paracolic gutters, VARD 
or traditional necrosectomy are more appropriate, due to the limited exposure with 
this method. These limitations are counterbalanced by the minimal amount of 
mobilization required to enter the lesser sac by the transgastric method. [35]
When performed laparoscopically, five ports are typically placed; in addition 
to an umbilical port, two ports are placed in the right upper quadrant, one port is 
placed in the left upper quadrant, and one port in the epigastrium. After enter-
ing the abdomen and creating the anterior gastrotomy, an ultrasound is used to 
identify the necrosis and plan the locations of the posterior gastrotomy. Ultrasound 
is adjunctive to preoperative imaging, which is also essential to surgical planning. 
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Both anterior and posterior gastrotomies should be made after placement of stay 
sutures. Upon entering the lesser sac, necrosectomy should be performed with 
blunt instruments, such as a ring forceps, taking great care to remove only loose 
material and avoid avulsing adherent tissue or vessels that may be bridging the area 
of necrosis. Following necrosectomy, a cystogastrostomy is created with an endo-
scopic stapler, or suture. The anterior gastrotomy is then closed with sutures or with 
a stapler. [36]
When performed open, an upper midline incision is made, and the procedure 
proceeds in the same fashion as in the laparoscopic procedure. One difference in the 
open procedure is that many surgeons elect to use digital dissection for the necro-
sectomy, as opposed to instruments. [37]
Open and laparoscopic approaches to transgastric drainage have been shown 
to have similar outcomes. In a recent retrospective review of patients from three 
tertiary referral centers, rates of morbidity, including rates of reoperation and 
hemorrhage, and mortality were not significantly different. However, the patients 
who underwent laparoscopic drainage had a higher rate of readmission. It should 
be noted that the overall mortality in this study was 2% at an average follow-up of 
21 months, significantly less than reported elsewhere in the literature. The overall 
morbidity rate of 38% is in alignment with commonly reported rates elsewhere in 
literature. [38]
Although surgical transgastric necrosectomy is relatively well tolerated, out-
comes favor endoscopic transgastric drainage. Meta-analysis comparing the two 
show lower rates of overall major complications, pancreatic fistula formation, 
post-procedural organ failure, and hernia with an endoscopic approach. However, 
the overall rate of clinical resolution, post-operative bleeding, endocrine dysfunc-
tion, exocrine insufficiency, and mortality were not significantly different. [39] 
Thus, surgical transgastric necrosectomy is a valid alternative to other approaches 
of necrosectomy in the absence of an experienced endoscopist or at a center without 
access to advanced endoscopic tools.
7. Laparoscopic and open necrosectomy
Although utilization of a drainage tract and the transgastric approach are 
important for management of pancreatic necrosis, traditional laparoscopic and 
open necrosectomy methods also continue to be utilized.
For laparoscopic necrosectomy, patients are typically placed in lithotomy 
position, with the operating surgeon standing between the legs. An umbilical port 
is placed first. Upon entering the abdomen, a diagnostic laparoscopy should be 
performed. Subsequently, two left lateral ports and an epigastric port are placed. 
In some cases, a hand-assist port is placed to augment dissection and removal of 
tissue. Following lysis of adhesions, a transgastrocolic, for pancreatic head or body 
necrosis, or transmesocolic, for pancreatic tail necrosis, approach to retrogastric 
necrosectomy can be taken. (Figure 2) Upon entering the area of necrosis, blunt 
instruments are used to remove loose, necrotic tissue. This tissue is then placed 
into an endocatch bag for removal from the abdomen. Dissection is alternated with 
irrigation and suction to remove as much necrotic tissue as possible. [40] Once the 
necrosectomy is complete, large drainage catheters are placed in the cavity, which 
also allow for post-operative irrigation. At this time, consideration should also 
be given to cholecystectomy, if gallstones were implicated in the development of 
pancreatitis, and to nutritional access. Depending on the specific study, mortality 
for patients who require laparoscopic necrosectomy ranges from 10 to 18%. Rates of 
reoperation also vary widely, ranging from 11 to 38%. [41, 42]
Pancreatitis
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The most invasive procedure used for the treatment of pancreatic necrosis 
is the open debridement. This technique is reserved for patients that fail other 
less invasive techniques, or patients who require concurrent intervention for 
another intraabdominal process, such as bowel ischemia or abdominal compart-
ment syndrome. Unless midline laparotomy is required for another indication, 
the abdomen can be opened with bilateral, subcostal incisions. The gastrocolic 
ligament is then opened, and the stomach is reflected superiorly, exposing the 
lesser sac. (Figure 2) The transverse mesocolon is then opened, exposing the 
retroperitoneum. The hepatic and splenic flexures of the transverse colon are 
often taken down at this point. A Kocher maneuver may also be necessary if the 
area of necrosis involves the head of the pancreas. Once the pancreas is adequately 
exposed, blunt debridement can begin. This is usually accomplished with digital 
dissection or with lavage in order to minimize the risk of bleeding or bile duct 
injury. These risks must be balances with adequate removal of loose, nonviable 
tissue. Wide drainage of the area with a sumping tube (i.e. Abramson drain) can 
facilitate continue lavage and debridement. The quality of the initial necrosec-
tomy predicts the need for subsequent operations.
After necrosectomy, the abdomen may be kept open, with packing in place, 
to allow for repeated removal of necrotic tissue. Alternatively, the closed packing 
technique can also be used. This technique consists of filling the cavity created 
by the necrosectomy with gauze-filled Penrose drains. The drains are removed 
one at a time, until the cavity closes. [43] A third option is continuous irrigation, 
where large catheters are placed into the lesser sac under direct visualization. 
Additional drainage catheters are left in the peritoneal cavity. The abdomen is 
then closed and the large catheters are used for continuous installation of hyper-
tonic fluid. [44]
As in patients who undergo laparoscopic necrosectomy, the rates of morbid-
ity and mortality following open necrosectomy are high. Rates of post-operative 
morbidity range from 34 to 95% and mortality ranges from 6 to 47%, depending 
on the pre-operative severity of illness. Rates of reoperation vary depending on the 
packing technique. When the abdomen is left open, reoperation is planned rather 
than required because of deterioration or other complications, such as hemorrhage. 
Depending on the study, when the abdomen is left open, patients may return to the 
operating room from 1 to 17 time. Comparatively, relaparotomy is required in 17% 
of patients treated with closed packing require and 17–27% of patients treated with 
continuous irrigation. Rates of pancreatic fistula also differ depending on packing 
technique with a 25–46% rate in open abdomens, 53% rate in closed packing, and 
13–19% rate with continuous irrigation. [45]
The outcomes for both of these techniques are improved when intervention 
can be delayed at least 3 weeks. Delayed necrosectomy is associated with lower 
rates of exocrine and endocrine insufficiency, adverse post-operative events, 
including bleeding, and mortality. [17, 46] Early surgical intervention only pro-
vides a survival benefit in the case of decompression of abdominal compartment 
syndrome. [47, 48]
When compared directly, in a retrospective case series, the rates of pancreatic 
fistula, post-operative pulmonary infections, and surgical site infections were all 
significantly lower with laparoscopic necrosectomy. Additionally, patients who 
underwent laparoscopic necrosectomy also had a shorter length of stay, but a 
longer initial operation. There was no difference in need for reoperation, overall 
morbidity, or mortality. It should be noted that mortality was very low compared 
to other literature in this study, 5.9% in the open group and 4% in the laparoscopic 
group. [49]
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8. Disconnected pancreatic duct syndrome
While parenchymal destruction in pancreatic necrosis confers significant 
morbidity and mortality, the seriousness of this condition can be further com-
pounded by concurrent disruption of the pancreatic duct. Disconnected pancreatic 
duct syndrome (DPDS) occurs when the remnant of pancreas distal to the necrosis, 
and duct disruption, remains viable and continues to release digestive enzymes into 
the retroperitoneum. DPDS most commonly occurs in the setting of severe acute 
pancreatitis, and can be found in up to 46% of patients with pancreatic necrosis. 
[50] DPDS can also occur as the result of trauma and chronic pancreatitis. The clini-
cal presentation of DPDS is heterogenous. Some patients are asymptomatic and the 
injury is incidentally diagnosed on radiology. While others may have early satiety 
due to the size of the resulting fluid collection or symptomatic ascites. [51, 52]
DPDS is an often overlooked complication due to the low accuracy of imaging in 
differentiating between full-thickness pancreatic necrosis, affecting the pancreatic 
duct, and partial thickness or peripancreatic necrosis. Often multiple imaging 
modalities are required for accurate diagnosis, which in turn leads to delays in 
diagnosis, increased morbidity, and increased costs. [53–55] Diagnostic criteria for 
DPDS include: necrosis of ≥2 cm of pancreatic parenchyma, viable pancreatic tissue 
distal to the area of necrosis, and extravasation of contrast when injected into the 
main pancreatic duct during ERCP. [56]
Once DPDS is diagnosed, choice of intervention is dependent on the patient’s 
clinical condition and the phase of disease. As in pancreatic necrosis without 
DPDS, intervention during the acute phase, when inflammation is high, is not only 
challenging, but also hazardous. Although the historical standard of care for these 
patients was surgery, if a patient deteriorates during the acute phase, initial therapy 
should be percutaneous or endoscopic. Percutaneous drainage, although useful 
as a temporizing measure, especially in unstable patients, is unlikely to succeed 
as monotherapy. [57, 58] Although success rates are dependent on the extent of 
necrosis, transpapillary and transmural endoscopic interventions have better short-
term outcomes, with up to an 87% success rate of fistula resolution. [50, 59, 60] 
However, in order for endoscopic treatment to be successful, multiple interventions 
are often required, including hybrid approaches with percutaneous drains. Further, 
long-term data regarding patency and migration of indwelling stents is not avail-
able. [60, 61] Thus, percutaneous and endoscopic treatments remain temporizing 
measures, rather than definitive treatment, for DPDS, except for in patients who 
are poor surgical candidates. [62]
Once a patient reaches the late stage of disease, or if a patient deteriorates 
despite optimal percutaneous and endoscopic intervention during the acute phase, 
surgery becomes the primary treatment for DPDS. Because of the technical dif-
ficulty of operating in the retroperitoneum after tissue planes have been obscured 
by inflammation, and because of the frequency of splenic vein thrombosis, and 
resulting sinistral portal hypertension, this operation is usually performed with a 
midline laparotomy and not laparoscopically. [63]
Surgery for DPDS consists of resection of the distal, disconnected pancreas, and 
creation of internal drainage tracts. These techniques may be used independently 
or in combination. When the entirety of the disconnected pancreas is resected, 
splenectomy is also performed in almost all cases. However, when a pancreatoje-
junostomy, pancreaticogastrostomy, or fistuloenterostomy is made with the viable 
distal pancreas, the spleen may be preserved, in addition to preserving the pancre-
atic remnant. In this way, internal drainage not only provide a conduit for pancre-
atic secretions, but also decreases the risk of exocrine pancreatic insufficiency and 
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diabetes. Importantly, patients who undergo internal drainage, compared to other 
surgical modalities, also have lower incidence of organ failure, development of 
pancreatic fistula, and need for long-term percutaneous drainage. [50, 64]
9. Conclusions
Pancreatic necrosis is a significant and challenging disease process with 
mortality reaching beyond 30% in most studies. Intervention begins with sup-
portive care and nutritional support. However, invasive therapy is often needed, 
especially when necrosis becomes infected.
First-line interventions for pancreatic necrosis may be percutaneous or trans-
mural endoscopic drainage depending on if the necrosis is encapsulated, the 
accessibility of the necrosis, the patient’s clinical condition, and the capabilities of 
the hospital. These minimally-invasive interventions are often successful as mono-
therapy, without the need for further intervention. They are also preferable to open 
or laparoscopic necrosectomy when performed as part of a step-up approach.
Despite all of the improvement in minimally-invasive management of pancreatic 
necrosis, some percentage of patients continue to require surgical intervention. 
Both laparoscopic and open approaches have been shown to be effective via trans-
gastric, transgastrocolic, and transmesocolic routes.
When pancreatic necrosis is further complicated by a disconnected pancreatic 
duct, although minimally-invasive management has been described and shown to 
be effective, surgical management remains standard of care.
Despite the advances in care driven by clinical trials and new technology, man-
agement of pancreatic necrosis remains difficult. Further study is needed to reduce 
the morbidity and mortality of this devastating disease.
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Appendices and Nomenclature
ACN acute necrotic collection
CT computed tomography
DEN direct endoscopic necrosectomy
DPDS disconnected pancreatic duct syndrome
ERCP endoscopic retrograde cholangiopancreatography
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EUS endoscopic ultrasound
FNA fine needle aspiration
HU Hounsfield units
PEN percutaneous endoscopic necrosectomy
SEMS self-expanding metal stent
TPN total parenteral nutrition
WON walled of necrosis
VARD video-assisted retroperitoneal debridement
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